ABCD1 | ATP-binding cassette, sub-family D (ALD), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCD4 | ATP-binding cassette, sub-family D (ALD), member 4 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCE1 | ATP-binding cassette, sub-family E (OABP), member 1 | Mitochondrial proteins
| | | | | Expressed in all |
ABCF1 | ATP-binding cassette, sub-family F (GCN20), member 1 | Plasma proteins
| | | | | Expressed in all |
ABCF2 | ATP-binding cassette, sub-family F (GCN20), member 2 | | | | | | Expressed in all |
ABCF3 | ATP-binding cassette, sub-family F (GCN20), member 3 | | | | | | Expressed in all |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
ABCG4 | ATP-binding cassette, sub-family G (WHITE), member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABHD10 | Abhydrolase domain containing 10 | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
ABHD11 | Abhydrolase domain containing 11 | Disease related genes
| | | | | Expressed in all |
ABHD12 | Abhydrolase domain containing 12 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ABHD13 | Abhydrolase domain containing 13 | Predicted membrane proteins
| | | | | Expressed in all |
ABHD14A | Abhydrolase domain containing 14A | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ABHD14B | Abhydrolase domain containing 14B | Plasma proteins
| | | | | Expressed in all |
ABHD15 | Abhydrolase domain containing 15 | Predicted secreted proteins
| | | | | Mixed |
ABHD16A | Abhydrolase domain containing 16A | Predicted membrane proteins
| | | | | Expressed in all |
ABHD17A | Abhydrolase domain containing 17A | | | | | | Expressed in all |
ABHD17B | Abhydrolase domain containing 17B | | | | | | Expressed in all |
ABHD17C | Abhydrolase domain containing 17C | | | | | | Mixed |
ABHD2 | Abhydrolase domain containing 2 | Predicted membrane proteins
| | | | | Expressed in all |
ABHD3 | Abhydrolase domain containing 3 | Predicted membrane proteins
| | | | | Expressed in all |
ABHD4 | Abhydrolase domain containing 4 | Enzymes
| | | | | Expressed in all |
ABHD5 | Abhydrolase domain containing 5 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ABHD6 | Abhydrolase domain containing 6 | Enzymes Predicted membrane proteins
| | | | | Mixed |
ABHD8 | Abhydrolase domain containing 8 | | | | | | Mixed |
ABI1 | Abl-interactor 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Expressed in all |
ABI2 | Abl-interactor 2 | Cytoskeleton related proteins
| | | | | Expressed in all |
ABI3 | ABI family, member 3 | | | | | | Tissue enhanced |
ABI3BP | ABI family, member 3 (NESH) binding protein | Plasma proteins Predicted secreted proteins
| | | | | Mixed |
ABL1 | C-abl oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
ABL2 | C-abl oncogene 2, non-receptor tyrosine kinase | Cancer-related genes Enzymes RAS pathway related proteins
| | | | | Expressed in all |
ABLIM1 | Actin binding LIM protein 1 | | | | | | Expressed in all |
ABLIM2 | Actin binding LIM protein family, member 2 | | | | | | Tissue enhanced |
ABLIM3 | Actin binding LIM protein family, member 3 | Plasma proteins
| | | | | Tissue enhanced |
ABR | Active BCR-related | | | | | | Expressed in all |
ABRACL | ABRA C-terminal like | Plasma proteins
| | | | | Mixed |
ABTB1 | Ankyrin repeat and BTB (POZ) domain containing 1 | | | | | | Expressed in all |
ABTB2 | Ankyrin repeat and BTB (POZ) domain containing 2 | | | | | | Mixed |
AC004381.6 | Putative RNA exonuclease NEF-sp | | | | | | Tissue enriched |
ACAA1 | Acetyl-CoA acyltransferase 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
ACAA2 | Acetyl-CoA acyltransferase 2 | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ACACA | Acetyl-CoA carboxylase alpha | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ACACB | Acetyl-CoA carboxylase beta | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACAD11 | Acyl-CoA dehydrogenase family, member 11 | | | | | | Expressed in all |
ACAD8 | Acyl-CoA dehydrogenase family, member 8 | Disease related genes Mitochondrial proteins
| | | | | Expressed in all |
ACAD9 | Acyl-CoA dehydrogenase family, member 9 | Disease related genes Mitochondrial proteins
| | | | | Expressed in all |
ACADL | Acyl-CoA dehydrogenase, long chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Mixed |